Deal Summary

Disc Medicine

$200,000,000

Non-Dilutive Term Loan

Hercules Capital

Deal Notes:

$200M facility supports pipeline catalysts; initial $30M funded, additional tranches available based on milestones; provides 48-60 months interest-only period
Loan maturing in Nov 2029; Armentum Partners advised

Industry:

Biopharmaceutical

Role:

Debt Financing

Event:

Expansion

Recent Deal Announcements